The Deal Register
Database › Debt financing › HLS Therapeutics Announces New Credit Agreement

Debt financing

HLS Therapeutics Announces New Credit Agreement

Lane
Debt financing
Announced
20 Aug 2025
Province
Ontario
Industry
Healthcare & life sciences
Status
Announced
What the filing says
HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS ), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that the company has entered into a new Credit Agreement (the "Agreement") with National Bank of Canada ("National Bank") as administrative agent which provides for committed credit facilities denominated in Canadian dollars of up to CAD $107 million (USD ~$77.5 million ).
Terms stated
maturity date
Source

The terms are in the subscriber edition

This transaction carries 2 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe